Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
about
The Role of Dietary Inflammatory Index in Cardiovascular Disease, Metabolic Syndrome and MortalityThe impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular diseaseC-reactive protein and coronary heart disease: all said--is not it?Mendelian randomization studies: a review of the approaches used and the quality of reportingInflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysisMendelian randomization: genetic anchors for causal inference in epidemiological studiesC-reactive protein in human atherogenesis: facts and fictionFcγ receptors and ligands and cardiovascular diseaseMendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the futureOvercoming Challenges With Statin TherapyCan persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease?Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three StudiesInvestigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization StudyMendelian randomization in cardiometabolic disease: challenges in evaluating causality.Socioeconomic status in childhood and C reactive protein in adulthood: a systematic review and meta-analysis.The Role of Emerging Risk Factors in Cardiovascular OutcomesMendelian Randomization as an Approach to Assess Causality Using Observational Data.Body mass index: Has epidemiology started to break down causal contributions to health and disease?Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies.Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.Animal models of C-reactive protein.The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk.Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease.Genetic and environmental influences on the prospective correlation between systemic inflammation and coronary heart disease death in male twins.Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease.Genetics of human cardiovascular diseaseChanges in mipomersen dosing regimen provide similar exposure with improved tolerability in randomized placebo-controlled study of healthy volunteersInstrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin D on colorectal cancer risk: a mendelian randomization analysis.Life course socioeconomic position and C-reactive protein: mediating role of health-risk behaviors and metabolic alterations. The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.Risk of cardiovascular disease in a traditional African population with a high infectious load: a population-based studyHIV-infection, atherosclerosis and the inflammatory pathway: candidate gene study in a Spanish HIV-infected population.HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease.Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.A lack of association between the CRP rs2794520 polymorphism and coronary artery disease.
P2860
Q26741434-74B750CA-0730-44EC-98A1-942E411BA796Q26748869-17CC6ED1-1C0D-4CE0-BB8C-471C8039C24AQ26860959-5D0BEE6A-AD7A-43BA-B686-2102B2B6F883Q26999349-6468A570-8853-44E0-9C53-D39D360208B7Q27001736-3093DCD8-B616-4DA9-8B0C-E750A499056DQ27002487-84FE456C-7BEE-45F4-B0AF-4F0D0E167382Q27013635-938DCEC5-19A8-4E7E-9A86-6C326A1781DBQ27021449-B1EC8AB9-60DB-4516-A183-155832D34A72Q28070061-DB451EB1-DAE6-46F7-A253-6EAA27CD8902Q28073319-CA3E15E8-BF9B-48ED-806E-3D9D42CA6293Q28260861-97E8B499-5731-49C8-8934-219FB0D253FAQ28552731-AEC9ABFC-04BF-4EC1-90C5-5BE86E83C767Q28600936-3A052F50-CD39-4166-ADFD-832AD689B385Q30234302-3C299BC6-1B3F-4C7B-BAA7-CE6D1CF0237FQ30234507-686B784E-9AD8-42A7-B7CD-154194B604DEQ30234550-7CE8CDFA-E450-4E83-BF1E-C809315C5C98Q30243892-798253A7-021C-4A34-AFA7-FA67BF140CDAQ30248778-B2D28BCE-4555-4376-B5D3-8DA838E36192Q30414047-75961D57-8AC5-4C5E-B591-15B065A7FB33Q30489063-82DE66DD-05DD-440E-9303-1A3FC002B253Q30870962-FA23813D-8B93-4055-A5AC-36F53B1FE085Q30910636-0DD3EB45-3428-4140-BB9B-77C2CF98E692Q33570959-CCF8797D-2109-4309-B312-953280EBC774Q33607563-4C2EEF38-87EB-4BBC-A139-33CFEF792B6BQ33632047-5FC96EFB-479F-4FD1-9393-CD3AAD814A60Q33796862-FC0AAF94-4EEA-43DA-90D9-79DE48F1A2E5Q33905741-F753B5FB-A4E6-4BE6-8C0E-B0C8C83BBAF1Q33916015-8CD21DAE-318F-4F68-84A7-E958B194BE45Q34180517-9AF0F1BA-0C48-4D94-BD99-F9D0B64C4537Q34236472-D292FCF6-E3CF-4120-A389-0399F742D5E4Q34261931-A8325BDD-C06D-4C7C-A659-95C12A9282D9Q34297049-7D6FFF28-A3E1-4066-9BEA-EC9C050807CFQ34305165-C7C5CC5D-CA08-482B-83B9-5FDE2DC8C7D7Q34331587-FA2C03FD-9E8A-4877-B84B-0009710F8E02Q34405742-5795FD4A-E710-49A3-9AF0-1C76686552A4Q34447546-3265292D-BC6B-439D-ABF6-392A86E1B360Q34482615-5140D360-E9B0-4616-AEBF-05BF0C3D2AB8Q34532933-8987D789-CE3A-4449-9E84-04B4D5E05431Q34534979-9E0FB683-3241-4521-9133-A3F5BF64301BQ34607241-7A9E67BD-C032-4454-82DB-0B14B877367C
P2860
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Association between C reactive ...... on individual participant data
@ast
Association between C reactive ...... on individual participant data
@en
Association between C reactive ...... on individual participant data
@nl
type
label
Association between C reactive ...... on individual participant data
@ast
Association between C reactive ...... on individual participant data
@en
Association between C reactive ...... on individual participant data
@nl
prefLabel
Association between C reactive ...... on individual participant data
@ast
Association between C reactive ...... on individual participant data
@en
Association between C reactive ...... on individual participant data
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Association between C reactive ...... on individual participant data
@en
P2093
Frances Wensley
George Davey-Smith
James C Engert
John Danesh
Juan Pablo Casas
Manjinder Sandhu
Mark B Pepys
Robert Clarke
Simon G Thompson
P2860
P3181
P356
10.1136/BMJ.D548
P407
P433
P50
P577
2011-02-15T00:00:00Z